2), and some reports indicate that plant E2F/DP factors play a role at the G1/S transition (3, 4). By contrast, different mechanisms for G2/M phase-specific transcription have been proposed in plants and animals. In animal cells, G2/M phase-specific transcription is mainly regulated by two repressor elements known as CDE (cell cycle-dependent element) and CHR (cell cycle gene homology region; for revew, see ref. 5). These elements are found in the promoters of various G2/M phase-specific genes, which include cdc25C (6), polo-like kinase (7), aurora A (8), and cyclin B2 (9). Mutation of the CDE and CHR elements allows elevated transcription during G1 and consequent loss of cell cycle-regulated expression. In plants, G2/M phase-specific genes do not contain these repressor elements but, instead, they contain a common cis element called the M phase-specific activator sequence (MSA), which is necessary and sufficient for the G2/M phase-specific activation of promoters (10, 11) . We showed previously that members of a group of Myb transcription factors bind to MSA elements and regulate transcription by activating or repressing promoter activity Thus, such plant Myb proteins are often called R2R3-Myb. We recently identified three Myb proteins, NtmybA1, NtmybA2, and NtmybB, that bind to the MSA motif in tobacco (12). These Myb proteins contain three repeats (R1, R2, and R3), and each repeat is more closely related to the vertebrate Myb repeats than to the repeats from plant R2R3-Myb proteins. Thus, Myb proteins with three repeats from plants and animals constitute an evolutionarily conserved group in the Myb superfamily, and they are referred to collectively herein as three-repeat Myb (3Rmyb) proteins. Closely related 3Rmyb proteins are also found in Drosophila and the slime mold Dictyostelium discoideum but they are not found in the nematode Caenorhabditis elegans or in budding yeast (16). Animals do not have Myb proteins that are related to plant R2R3-Myb proteins.
5 similar role at the G2/M phase was also reported for a 3Rmyb protein in Drosophila (17) .
In plants, a wide range of G2/M phase-specific genes appear to be regulated by 3Rmyb
proteins. A recent analysis of the Arabidopsis transcriptome, using a DNA tip, revealed that 93 of 8,250 genes tested showed G2/M phase-specific expression, with similar kinetics of expression to those of cyclin B genes (18) . Among these 93 genes, approximately 20% include MSA consensus sequence YCYAACGGYY (where Y indicates C or T) in the promoter region, defined as the 1-kb region upstream of the site of initiation of translation. The tobacco NACK1 gene is the best-characterized example in this group of plant genes. The G2/M phase-specific transcription of NACK1 is dependent on the two MSA motifs in its promoter region (12) . NACK1 is an M phase-specific kinesinlike protein that has been identified as an activator of NPK1, a MAP kinase kinase kinase that is required for formation of the cell plate during cytokinesis in tobacco (19) .
The two 3Rmyb proteins in tobacco, NtmybA1 and NtmybA2, are structurally related to each other and function as transcriptional activators, while NtmybB, with a less closely related structure, also binds to the MSA element but functions as a competitive repressor (12) . We showed that both cyclin B and NACK1 promoters were activated by NtmybA1 and NtmybA2 and were repressed by NtmybB in cotransfection experiments. Levels of 6 3Rmyb proteins, which is further regulated by transcriptional control of NtmybA1 and NtmybA2 genes themselves. We report here that another level of regulation is operational for the cell cycle-regulated activities of NtmybA1 and NtmybA2. We show that the transactivation potential of NtmybA2 is repressed by the protein's own C-terminal region and that cyclin-dependent kinases (CDKs) appear able to relieve this inhibitory effect, most probably via the direct phosphorylation of NtmybA2. Our results indicate that the G2/M phase-specific activities of NtmybA2 and, possibly, NtmybA1 are controlled by multiple mechanisms.
EXPERIMENTAL PROCEDURES

Plant Material and Synchronization of Cells
Maintenance and synchronization of tobacco (Nicotiana tabacum) BY2 cells were performed as described previously (20, 21) . In brief, BY2 cells were synchronized by treatment with aphidicolin (5 mg/liter; Wako, Osaka, Japan) for 24 h and subsequent washing with fresh medium to release the aphidicolin block. Mitotic indices were determined by examining cells that had been stained with a 1% solution of orcein in a mixture (1:1, v/v) of lactic acid and propionic acid.
Construction of Plasmids
The reporter plasmid containing the NACK1 promoter fused to a luciferase (LUC) reporter gene (NACK1p-LUC) was described previously (12) . The 4¥GAL4-LUC reporter plasmid contains four copies of a GAL4-responsive element upstream of a LUC reporter gene and by guest on http://www.jbc.org/ Downloaded from has been described elsewhere (22) . The expression plasmid for full-length NtmybA2 (pJIT-NtmybA2) was constructed by inserting NtmybA2 cDNA at a SalI site located downstream of the double Cauliflower mosaic virus (CaMV) 35S promoter in pJIT60 (23) .
A series of C-terminally truncated versions of NtmybA2, namely D187, D242, D568, D630, and D704, was generated by PCR from pJIT-NtmybA2 using a sense primer that corresponded to the sequence TATCCTTCGCAAGACCCTTC in the pJIT-60 vector, and following antisense primers, which include SalI sites and stop codons,
CCGTCGACTACTTTTTGACGGAACTATTCC
(for D187 (12) .
Transient Expression Assays with BY2 Protoplasts
Tobacco BY2 protoplasts were prepared from three-day-old cells as described previously (28) . Protoplasts were transfected by polyethylene glycol-mediated direct gene transfer (29) , and transfected protoplasts were cultured for 24 h at 27˚C. For each construct, five independent transfections were performed. A dual-luciferase reporter assay was promoter, was performed to provide an internal control for the efficiency of transfection.
Particle Bombardment
BY2 cells from an eight-day-old culture were diluted ten-fold with fresh medium, spread in a thin layer over filter paper, and then subjected to particle bombardment, which was performed as described previously (12) . After bombardment, cells were suspended in fresh medium with or without aphidicolin (20 mg/l) and cultured at 27˚C. Cells were harvested 24 h after bombardment, and the activities of firefly luciferase and Renilla luciferase were determined as noted above.
Assays of Kinase Activities in vitro
For bacterial expression of recombinant protein, cDNA fragments that encoded the Cterminal region of NtmybA2 (amino acids 441-1042) with or without mutations were cloned at the BamHI/SalI sites of the pET28a vector (Novagen, Darmstadt, Germany). The
NtmybA2 recombinant protein tagged with His-T7 was produced in E. coli (DE3) pLysS.
After lysis of cells, the insoluble fraction was denatured and solubilized in 8 M urea and then the His-tagged recombinant protein was purified on a HiTrap Chelating TM column (Amersham Pharmacia Biotech., Buckinghamshire, UK). The eluate was dialyzed and concentrated with an Ultrafree Bio-Max NMWL membrane unit (Millipore, Billerica, MA, USA), and was used as a substrate for kinase reactions in vitro.
Purification of a CDK fraction from BY2 cells and kinase reactions in vitro were performed as described previously (30) . In brief, BY2 cells were homogenized with HG150 buffer (25 mM Tris-HCl, pH 7.5, 10 mM EDTA, 10 mM EGTA, 150 mM NaCl, 10% glycerol, 1 mM DTT, 20 mM b-glycerophosphate, 1 mM sodium o-vanadate, 1 mM NaF, 1 mM PMSF, 1% Triton-X100 and 1% NP-40 plus 5 mg/ml leupeptin, 5 mg/ml chymostatin, 5 mg/ml pepstatin A and 5 mg/ml antipain), and centrifuged. Extracts of BY2 cells were rotated gently with 20 ml of p13 SUC1 -agarose beads (50% slurry; Upstate Biotechnology, Lake Placid, NY, USA) at 4˚C for 2 h. Beads were washed four times with
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E. coli and purified as described above. CDK fractions were prepared as described above from BY2 cells that had been arrested at prometaphase for enrichment of mitotic protein kinases. For induction of prometaphase arrest, BY2 cells were first synchronized by treatment with aphidicolin for 24 h. After release from the aphidicolin block, cells were cultured for 4 h in fresh medium without the drug, and then they were treated with propyzamide (Sumitomo Chemical, Osaka, Japan) at a final concentration of 6 mM. Cells were cultured in the presence of propyzamide for a further 6 h and then collected for preparation of the CDK fraction.
RESULTS
Cell Cycle-Regulated Activity of NtmybA2
We showed previously, in cotransfection experiments, that the MSA-containing promoters of the cyclin B and NACK1 genes are significantly activated upon expression of NtmybA1 or NtmybA2 (12) . To determine whether the transactivation activity of NtmybA2 is dependent on the stage of the cell cycle, we performed cotransfection experiments with asynchronously dividing tobacco BY2 cells and with aphidicolin-treated BY2 cells that were arrested at the S phase. We introduced a reporter plasmid that contained the NACK1 promoter fused to a luciferase (LUC) gene (NACK1p-LUC) into BY2 cells by particle bombardment. We tested two different expression plasmids. One encoded the full-length 
The Activity of NtmybA2 Is Repressed by Its C-Terminal Region
The domain structure of NtmybA2 is shown in Figure 2A . 
NtmybA2 Is Activated by Cyclins through Its C-Terminal Region
The negative regulatory domain that we identified in the C-terminal region of NtmybA2 contained multiple potential sites of phosphorylation by CDKs ( Fig. 2A) , raising the possibility that this region might act as an inhibitory domain that is regulated by phosphorylation during the cell cycle. To examine whether the activity of NtmybA2 might be controlled by cyclins, we cotransfected BY2 protoplasts with expression plasmids for full-length NtmybA2 and expression plasmids for various tobacco cyclins. In plants, cyclins A, B, and D are encoded by multigene families, each of which is further subdivided into three to seven subfamilies on the basis of amino acid sequences and expression profiles during the cell cycle (35, 36) . It is believed that plants do not have cyclin E, since the Arabidopsis genome does not contain genes that are homologous to
animal cyclin E. In this study, we examined the effects of cyclins from the B1-, A1-, A2-, A3-, and D3-type subfamilies from tobacco, which are herein designated CycB1, CycA1, CycA2, CycA3, and CycD3, respectively (Fig. 3A) . We examined effects of the cyclins on NtmybA2 alone enhanced the activity of the NACK1 promoter, increasing it to four to five times that in the control. However, when both NtmybA2 and some of the individual cyclins were expressed in combination, we observed even higher levels of NACK1 promoter activity. This superactivation of the NACK1 promoter was not caused only by the stimulatory effects of the cyclins on the cell cycle since the expression plasmids for the individual cyclins, by themselves, had no significant effects on the activity of the NACK1 promoter (Fig. 3A) . The superactivation depended upon the type of cyclin. Thus, CycB1, CycA1, and CycA2 mediated superactivation, while CycA3 and CycD3 did not. We obtained similar results when we used the expression plasmid for NtmybA1 (data not shown). The observed differences in the capacity for superactivation among the cyclins were not due to differences in levels of expression of the cyclins in the protoplasts since all the cyclins tested significantly increased kinase activity for histone H1 and the levels of activity were not correlated with the superactivation capacity of each cyclin (Fig. 3B) . The cyclin-induced superactivation of the NACK1 promoter was reversed by coexpression of a dominant negative form of a tobacco A-type CDK (CDKA), a member of a group of plant CDKs that is structurally most closely related to mammalian CDC2 (26) (Fig. 3C) . Thus, the effects of cyclins on the NACK1 promoter appeared to be mediated by the kinase activity of a CDK that bound to individual cyclins and the targets of phsophorylation by the CDK were most probably NtmybA1 and NtmybA2. The cyclin-induced superactivation was not specific to the NACK1 promoter; we obtained essentially the same results with a reporter plasmid fused to a cyclin B promoter (data not shown).
We attempted next to identify the region of NtmybA2 that was responsible for the cyclin-induced superactivation of the NACK1 promoter. We cotransfected BY2 protoplasts with expression plasmids for full-length or C-terminally truncated versions of NtmybA2 and the NACK1p-LUC reporter plasmid, with and without an expression plasmid for CycB1. For each form of NtmybA2, we determined the effects of the cyclin by comparing the NACK1p-LUC reporter activity with and without coexpression of the cyclin. As shown in Figure 3D , full-length NtmybA2 was able to mediate cyclin-induced superactivation, inducing two-fold higher reporter activity when CycB1 was coexpressed. However, the Cterminally truncated version of NtmybA2, ∆704, had lost the ability to mediate cyclininduced superactivation. Further deletion of NtmybA2 did not alter the capacity for mediating superactivation. The results were consistent with the hypothesis that specific cyclins counteract the inhibitory effect of the C-terminal domain of NtmybA2.
Cyclin-Induced Activation of NtmybA2 Does Not Require the DNA-Binding Domain
To confirm the function of the C-terminal domain of NtmybA2, we fused the C-terminal region of NtmybA2 that lacked the Myb domain (NtmybA2DMD) to the yeast GAL4 DNA binding domain (GAL4DBD). In addition, we fused GAL4DBD to a C-terminally truncated version of NtmybA2DMD (NtmybA2DMDDC) and to the VP16 activation domain (VP16AD) (Fig. 4A) . We introduced the expression plasmids for these GAL4
fusions into BY2 protoplasts together with a GAL4-responsive reporter plasmid that included the LUC reporter gene downstream from four copies of the GAL4-responsive element (4¥GAL4-LUC). All the GAL4 fusions examined significantly activated the 20 4¥GAL4-LUC reporter (Fig. 4B, open bars) . However, the transactivational activity of the GAL4-NtmybA2DMDDC fusion was close to 20 times higher than that of the GAL4-NtmybA2DMD fusion, suggesting again that the C-terminal region of NtmybA2 might negatively regulate the capacity for transcriptional activation. Then we tested the effect of cyclin on the transactivation potential of the GAL4 fusions. When the expression plasmid for CycB1 was introduced into BY2 protoplasts together with the expression plasmid for GAL4-NtmybA2DMD, superactivation of the GAL4-responsive reporter was observed 
Phosphorylation of NtmybA2 by CDK
To support the hypothesis that NtmybA2 is activated by CDK-mediated phosphorylation, we examined whether CDK can actually phosphorylate NtmybA2 in vitro (Fig. 5 ). We prepared a CDK fraction from BY2 cells using p13 SUC1 -agarose beads. p13 SUC1 is a wellcharacterized docking protein that binds with high affinity to CDKs (37) . As a substrate, an N-terminally deleted version of NtmybA2 (amino acids 441-1042) was produced in E.
coli (NtmybA2DN was strongly inhibited by the CDK-specific inhibitor roscovitine. To examine the cell cycle-dependent changes in kinase activity for NtmybA2, we synchronized BY2 cells using aphidicolin. Figure 6 shows that the mitotic index was highest 8 h after removal of aphidicolin. We prepared a set of p13 SUC1 -associated fractions from cells at different times, as indicated, and then examined the kinase activity with histone H1 and NtmybA2DN as substrates. The kinase activities of the p13 SUC1 -associated fractions did not change significantly during the cell cycle when histone H1 was the substrate. By contrast, there was a clear peak of kinase activity for NtmybA2DN 8 h after the removal of aphidicolin, coinciding with the highest mitotic index. These results provide strong evidence that NtmybA2 is a direct target of CDK. The timing of the peak of CDK activity for NtmybA2 was closely correlated with the timing of the function of NtmybA2, that is, the activation of transcription of G2/M phase-specific genes, such as the cyclin B and NACK1 genes.
Cyclin-Induced Activation of NtmybA2 Requires Potential Sites of Phosphorylation by CDK
NtmybA2 contains twenty possible sites (S/T-P motifs) of phosphorylation by CDK. To determine which sites among these S/T-P motifs might be relevant to the cyclin/CDKmediated regulation, we examined the effects of mutations of NtmybA2 at these potential sites of phosphorylation by CDK. The S/T-P motifs are located at amino acid positions 8, Figure 7A , we constructed expression plasmids for mutated NtmybA2 proteins that lacked potential sites of phophorylation in various combinations. Mutations were introduced such that the serine or threonine residue at individual potential sites of phosphorylation was changed to an alanine residue. When trasfected into BY2 protoplasts, all mutant forms tested enhanced the activity of the NACK1p-LUC reporter from two-to four-fold (Fig. 7B) . We then tested the effect of coexpression of cyclin (CycB1) on the activities of wild-type and mutant forms of NtmybA2 (Fig. 7C) . The ability of wild-type NtmbyA2 to transactivate the NACK1 promoter was increased approximately two-fold by coexpression of CycB1. This enhancing effect of CycB1 on activation of the NACK1 promoter was completely lost when all twenty potential sites of phosphorylation were mutated simultaneously ( (Fig. 7D) , as shown similarly in Figure 5 . When the mutant form of NtmybA2DN that lacked all S/T-P motifs was used as the substrate, the extent of phosphorylation was greatly reduced (Fig. 7D, NtmybA2DNm4-20) . Thus, it appears that most, if not all, of the CDK activity in the p13 SUC1 -associated fraction phosphorylated NtmybA2 at S/T-P motifs. The extent of phosphorylation of NtmybA2DNm4-20 was very low relative to that of NtmybA2DN and might represent the activities of other kinases that were co-purified in our CDK fraction. When NtmybA2DN containing mutations in motifs 11-20 or 4-10 was used as substrate, intermediate levels of phosphorylation were observed in both cases (Fig. 7 D) . The levels of phosphorylation of wild-type and mutant NtmybA2DN proteins in vitro were roughly correlated with the extents of cyclin-induced activation in co-transfection experiments. Thus, the results presented here support our hypothesis that direct phosphorylation of multiple S/T-P motifs by cyclin/CDK might be required for full activation of NtmybA2.
DISCUSSION
We showed previously that, in tobacco cells, 3Rmyb proteins control the transcription of various G2/M phase-specific genes, including cyclin B genes. The levels of transcripts for two tobacco 3Rmyb proteins, NtmybA1 and NtmybA2 are, themselves, regulated during the cell cycle and are highest just before the level of cyclin B transcripts reaches a maximum (12) . In this report, we showed that, in addition to the regulation at the transcription of genes for NtmybA1 and NtmybA2, the activities of the two proteins themselves are controlled by cyclin/CDK. We showed first that the transactivation potential of NtmybA2 is repressed by its C-terminal region. Deletion of this region dramatically increased the activity of NtmybA2. Next, we showed, in cotransfection experiments, that specific types of cyclin enhance the activity of NtmybA2 via the latter's C-terminal region. Finally, we showed, by kinase assays in vitro, that the C-terminal region of NtmybA2 is phosphorylated by CDK(s) and that the CDK activity for NtmybA2 is cell cycle-regulated, peaking at G2/M. Taken together, our data suggest that the Cterminal region of NtmybA2 is phosphorylated by a specific cyclin/CDK complex(es) at G2/M and that this phosphorylation removes the inhibitory effect of the C-terminal region, thereby activating NtmybA2 specifically at G2/M. In this study, we have not identified the substrate of CDK that is responsible for activation of NtmybA2. Our data do not exclude the possibility that CDK might phosphorylate some unidentified protein, which might then affect the activity of NtmybA2. However, it is likely that activation of NtmybA2 is due to (17), as we also demonstrated previously in tobacco (12) . However, it remains to be determined whether the activity of the Myb is regulated by cyclin in
Drosophila.
We 
